Company Filing History:
Years Active: 2018
Title: Hye Soun Eum: Innovator in Pharmaceutical Composition
Introduction
Hye Soun Eum is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of fibrosis treatment. His innovative work has led to the development of a unique pharmaceutical composition that holds promise for medical applications.
Latest Patents
Hye Soun Eum holds a patent for a pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives. This invention focuses on the use of these derivatives as an ingredient for preventing or treating fibrosis. The present invention provides a novel use of N1-cyclic amine-N5-substituted biguanide derivatives for preparing a medicine aimed at effectively inhibiting fibrosis by suppressing epithelial-mesenchymal transition (EMT). He has 1 patent to his name.
Career Highlights
Eum is currently associated with Immunomet Therapeutics Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for conditions related to fibrosis.
Collaborations
Some of his notable coworkers include Sung Wuk Kim and Soon Im Lee, who contribute to the collaborative efforts at Immunomet Therapeutics Inc. Their combined expertise enhances the potential for innovative breakthroughs in pharmaceutical research.
Conclusion
Hye Soun Eum is a distinguished inventor whose work in pharmaceutical compositions is paving the way for new treatments for fibrosis. His contributions are significant in the ongoing quest for effective medical solutions.